NWO

Ukrainian Ministry signs AI consumer intelligence company NWO.ai to strengthen its digital front line

Retrieved on: 
Friday, December 9, 2022
Information, Policy, Ambiguity, OODA, Partnership, Communication, Ministry, NWO, Intelligence, Russia, Formerly Used Defense Sites, Information policy, Natural language, Natural language processing, NLP, United States Air Force, Organization, Medical device, Culture

NEW YORK, Dec. 9, 2022 /PRNewswire/ -- NWO.ai, a leading predictive AI platform that helps prominent enterprises anticipate major changes in micro-trends, today announced its partnership with The Centre for Strategic Communication and Information Security within the Ministry of Culture and Information Policy of Ukraine.

Key Points: 
  • Part of the strategy is to flood the world with misinformation to confuse citizensaswellasbusiness andgovernmentleaders.
  • "In the war for words, narrative is king and todays information battle is digital.
  • About NWO.ai: NWO.ai is a leading strategic intelligence platform that is revolutionizing the future of external data for enterprises.
  • The Centre is focused on communication that is aiming to counter external threats, in particular information attacks of the Russian Federation.

Almonty Investigating the Construction of a Vertically Integrated Nano Tungsten Oxide Downstream Processing Plant to Supply South Korean Battery Anode and Cathode Manufacturing Industry

Retrieved on: 
Wednesday, March 30, 2022
Other Manufacturing, Technology, Semiconductor, Other Energy, Other Technology, Alternative Energy, Manufacturing, Energy, Mining, Minerals, Natural Resources, Niobium, Risk, EV, THIS, CEO, Downstream, WF6, Efficiency, Sale, OF, 40, UPDATE, KfW, ANY, Industry, Person, Tungsten hexafluoride, Terminology, KfW IPEX-Bank, Letter, AII, Forward-looking statement, Growth, Multimedia, Mining, IS, Program, World, Tungsten, Los Santos mine, Documentation, ALI, Deportation of North Koreans by the South Korean Government, NWO, Company, LOI, TSX, THE, Safety, Semiconductor, Electronics, APT, Operating Industries Inc., Landfill, Acquisition, Powder metallurgy, Rare-earth element, Sintering, Risk management, Molybdenum, Panasqueira, Almonty Industries

The battery industry also directly implements tungsten oxide into their formulations for anodes and cathodes.

Key Points: 
  • The battery industry also directly implements tungsten oxide into their formulations for anodes and cathodes.
  • South Korea is the largest per capita consumer of tungsten worldwide, however it imports 94.7% of its tungsten oxide from China.
  • In order to generate additional returns from the Sangdong Tungsten Mine, Almonty has therefore undertaken high level investigation of a vertically integrated nano tungsten oxide downstream processing plant which would be located on-site at the Sangdong Tungsten Mine.
  • The initial parameters that the Company has outlined for the Nano Tungsten Oxide Downstream Processing Plant include:
    Feed material: Sangdong Tungsten Mine and other Almonty mines globally as / if required.

SciBase Barrier technology part of major immunodermatology project

Retrieved on: 
Wednesday, March 23, 2022
Dutch Research Council, Biomarker, Skin, University, Meuro, SCIB, Research, Hospital, Data analysis, Consortium, University Medical Center Schleswig Holstein, Disease management, NWO, Atopic dermatitis, Patient, Pharmaceutical industry, Dermatology

NGID is a nationwide, large-scale project to unravel novel biomarkers for six different skin diseases.

Key Points: 
  • NGID is a nationwide, large-scale project to unravel novel biomarkers for six different skin diseases.
  • The importance of the skin barrier in diseases such as atopic dermatitis is well known, but until now it has not been possible to evaluate the barrier in routine clinical practice.
  • The inclusion of these SciBase products in this consortium is a testament to the robust diagnostic potential of the SciBase technology.
  • The opportunity for SciBase is to become an integral part of personalized atopic dermatitis management, and with the very high numbers of patients affected, this is one of the most significant opportunities for SciBase to date", says Simon Grant CEO SciBase.

Pittcon Announces Keynote Lecture

Retrieved on: 
Tuesday, September 21, 2021
Science, FEBS, ACS, IMSF, EMBO, Wallace H. Coulter, NWO, Mass spectrometry, Congress Center, Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, The arts, Mass, Thomson Medal, Georgia World Congress Center, Sir Hans Krebs Medal, Utrecht University, Wallace, Field, Proteomics, European Union, Faculty, Royal Netherlands Academy of Arts and Sciences, Research, Lecture, University of Georgia (Tbilisi), Education, GLOBE, Pharmaceutical industry

Pittsburgh, Pennsylvania, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Pittcon is honored to announce Professor Albert J. R. Heck as the 2022 Wallace H. Coulter Lecturer.

Key Points: 
  • Pittsburgh, Pennsylvania, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Pittcon is honored to announce Professor Albert J. R. Heck as the 2022 Wallace H. Coulter Lecturer.
  • The 2022 Coulter Lecture is entitled New Horizons in Mass Spectrometry: Sizing and Counting Particles by Native Mass Spectrometry.
  • Albert J. R. Heck is Distinguished Faculty Professor at the Science Faculty of Utrecht University (the Netherlands).
  • Pittcon is a catalyst for the exchange of information, a showcase of the latest advances in laboratory science, and a venue for international connectivity.

Aviceda Therapeutics Announces Additional World-Class Members to its Scientific Advisory Board

Retrieved on: 
Monday, September 20, 2021
Technology, Research, Infectious Diseases, Nanotechnology, Clinical Trials, Biotechnology, Health, Pharmaceutical, Science, Therapy, VU University Medical Center, JAK3, List of pathologists, KNAW, Dendrite, ERC, Cell, Royal Netherlands Academy of Arts and Sciences, Harvard Medical School, SCID, Aviceda, Inflammation, Pathology, Coronavirus Scientific Advisory Board (Turkey), Cell biology, IP, Immune system, Cancer research, Science, Amgen, JEM, HIV, COO, GA, UCLA, FIH, CSO, Molecular biology, Ghost, DNA repair, DNA, Geographic atrophy, Government, Autosome, Cancer Research UK, Doctor of Philosophy, College, Government of Northern Ireland, Society, Dendritic cell, College of American Pathologists, DNAR, II, NWO, Cancer, CLIA, Patient, Biomarker, Biology, CLEP, McClay, NIH, PNAS, Pharmaceutical industry, Vaccine, Medicine

Aviceda Therapeutics, an IND-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing additional members of its Scientific Advisory Board who will help shape ongoing research and development efforts.

Key Points: 
  • Aviceda Therapeutics, an IND-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing additional members of its Scientific Advisory Board who will help shape ongoing research and development efforts.
  • The new additional Aviceda Scientific Advisory Board members includes:
    Aviceda is honored and privileged to add new world-class scientists and renowned researchers to join our efforts in developing the next generation of glyco-immune therapeutics for the treatment of immune-dysfunction conditions, said Mohamed A. Genead, MD, Co-Founder & President of Aviceda Therapeutics.
  • She published more than 280 scientific papers in well recognized journals (Cell, Nature, Nature Immunology, PNAS, and JEM) and supervised 29 PhD students.
  • The Aviceda team is already building on the foundational work in the emerging field of glycobiology to develop potential therapeutics and interventional strategies.